Henry Ford Cancer Institute/Henry Ford Hospital — Detroit, Michigan

Henry Ford Cancer Institute/Henry Ford Hospital is a clinical research site located in Detroit, Michigan, United States 48202.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Henry Ford Cancer Institute/Henry Ford Hospital has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor, Non-small Cell Lung Cancer.

Sponsors: Daiichi Sankyo, University of Michigan Rogel Cancer Center, I-Mab Biopharma US Limited.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Henry Ford Cancer Institute/Henry Ford Hospital?

Henry Ford Cancer Institute/Henry Ford Hospital has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Henry Ford Cancer Institute/Henry Ford Hospital conducted?

Henry Ford Cancer Institute/Henry Ford Hospital has 4 clinical trials on record, with 1 currently active. Their work covers Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor, Non-small Cell Lung Cancer.

Is Henry Ford Cancer Institute/Henry Ford Hospital accredited by Crixeo Health?

Henry Ford Cancer Institute/Henry Ford Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Henry Ford Cancer Institute/Henry Ford Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.